Biolinq Incorporated announced that it will receive $50,000,000 in funding on December 13, 2023. The company will issue convertible corporate debt in the transaction. The company will issue securities pursuant to exemption provided under Regulation D.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8,580 JPY | -0.12% | 0.00% | -0.75% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
8,580 JPY | -0.12% | 0.00% | 3.93B | ||
290 CAD | +1.75% | 0.00% | 514M | ||